Thalidomide regulatory update

The U.K.'s NICE issued a final appraisal determination (FAD) related to the use of Celgene's thalidomide and Velcade bortezomib from Johnson & Johnson (NYSE:JNJ, New Brunswick, N.J.) to treat multip...